Secreted chemokines reveal diverse inflammatory and degenerative processes in the intervertebral disc of the STZ-HFD mouse model of Type 2 diabetes

Christian E Gonzalez,Rachana S Vaidya,Sade Williams Clayton,Simon Y Tang
DOI: https://doi.org/10.1101/2024.07.31.605332
2024-08-03
Abstract:The chronic inflammation present in type 2 diabetes causes many chronic inflammatory comorbidities, including cardiovascular, renal, and neuropathic complications. Type 2 diabetes is also associated with a number of spinal pathologies, including intervertebral disc (IVD) degeneration and chronic neck and back pain. Although confounding factors such as obesity are thought to increase the loads to the musculoskeletal system and subsequent degeneration, studies have shown that even after adjusting age, body mass index, and genetics (e.g. twins), patients with diabetes suffer from disproportionately more IVD degeneration and back pain. Yet the tissue-specific responses of the IVD during diabetes remains relatively unknown. We hypothesize that chronic diabetes fosters a proinflammatory microenvironment within the IVD that accelerates degeneration and increases susceptibility to painful disorders. To test this hypothesis, we evaluated two commonly used mouse models of diabetes - the leptin-receptor deficient mouse (db/db) and the chronic high-fat diet in mice with impaired beta-cell function (STZ-HFD). The db/db is a genetic model that spontaneous develop diabetes through hyperphagia, while the STZ-HFD mouse first exhibits rapid obesity development under HFD and pronounced insulin resistance following streptozotocin administration. Both animal models were allowed to develop sustained diabetes for at least twelve weeks, as defined by elevated hemoglobin A1C, hyperglycemia, and glucose intolerance. Following the twelve-week period, the IVDs were extracted in quantified in several measures including tissue-specific secreted cytokines, viscoelastic mechanical behavior, structural composition, and histopathologic degeneration. Although there were no differences in mechanical function or the overall structure of the IVD, the STZ-HFD IVDs were more degenerated. More notably, the STZ-HFD model shows a significantly higher fold increase for eight cytokines: CXCL2, CCL2, CCL3, CCL4, CCL12 (monocyte/macrophage associated), IL-2, CXCL9 (T-cell associated), and CCL5 (pleiotropic). Correlative network analyses revealed that the expression of cytokines differentially regulated between the db/db and the STZ-HFD models. Moreover, the STZ-HFD contained a fragmented and modular cytokine network, indicating greater complexities in the regulatory network. Taken together, the STZ-HFD model of type 2 diabetes may better recapitulate the complexities of the chronic inflammatory processes in the IVD during diabetes.
Physiology
What problem does this paper attempt to address?
The paper primarily explores the impact of Type 2 Diabetes (T2D) on Intervertebral Disc (IVD) degeneration, with a particular focus on how the diabetic environment accelerates the degeneration process by promoting inflammatory responses. The study employs two mouse models to simulate Type 2 Diabetes: one is a genetic model—leptin receptor-deficient mice (db/db), and the other is a non-genetic model—high-fat diet combined with streptozotocin-treated mice (STZ-HFD). The main objective of the paper is to compare the health status of the intervertebral discs under diabetic conditions in these two models, with a special focus on inflammation and its related complications. By conducting comprehensive assessments including inflammation analysis, genomic changes, degeneration and morphological evaluation, and mechanical function tests on the intervertebral discs, the study aims to reveal how Type 2 Diabetes exacerbates the degeneration process of the discs. Specifically, the paper attempts to answer the following questions: 1. Does the diabetic environment create a pro-inflammatory microenvironment in the intervertebral discs, thereby accelerating their degeneration and increasing susceptibility to painful diseases? 2. Does the STZ-HFD model better replicate the complex chronic inflammatory processes occurring in the intervertebral discs during diabetes? By comparing the expression of inflammatory factors, network structures, and the degree of disc degeneration in the two models, the researchers hope to validate the applicability and advantages of the STZ-HFD model in studying diabetes-related intervertebral disc complications.